Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524634 | NSE Symbol : | ISIN : INE058F01019 | Industry : Chemicals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
10-Mar-2025	10-Mar-2025	Amendments in Articles of Assoc.	This is to inform you that the Board at its meeting held today, i.e. 10 March, 2025 has inter alia approved the following: 1. Based on the recommendation of the Nomination and Remuneration Committee and Audit Committee, appointment of Sri. Aditya Akkineni (DIN 01629979) as Additional Director being a Whole-time Director designated as Chief Executive Officer, subject to approval of the members of the Company; 2. Alteration in Object and Liability Clause of the MOA of the Company and alignment of the existing MOA with provisions of the Companies Act, 2013, subject to approval of the members of the Company; 3. Alteration of AOA of the Company to align them with the provisions of the Companies Act, 2013 by substituting the new AOA in place of the existing AOA of the Company, subject to approval of the members of the Company. The Meeting of the Board commenced at 3.30 PM IST and concluded at 4.10 PM IST.
29-Jan-2025	11-Feb-2025	Quarterly Results	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2024. The Board Meeting to be held on 07/02/2025 has been revised to 11/02/2025 With reference to our earlier intimation dated 29th January 2025 and partial modification thereof, intimation is hereby given in terms of Regulation 29 read with Regulation 33 of SEBI (Listing Obligation and & Disclosure Requirements) Regulations, 2015, this is to inform you that, due to non-availability of certain Directors, the meeting of the Board of Directors of the Company which was scheduled to be held on Friday, 7th February, 2025 is postponed and now re-scheduled to be held on Tuesday, 11th February 2025 inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2024. (As Per BSE Bulletin dated on 06.02.2025) This is to inform that the Board of Directors at its meeting held today i.e. 11th February, 2025, has inter alia 1. Approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2024. 2. In-principally approved to amend the Object Clause of the Memorandum of Association ('MOA') of the Company, subject to approval of the Members of the Company and relevant regulatory authorities. The detailed amendments in this regard will be disseminated upon the formal approval of the Board of Directors of the Company. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 along with Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 12.15 PM and concluded at 2.50 PM. (As Per BSE Announcement Dated on 11/02/2025)
29-Oct-2024	08-Nov-2024	Quarterly Results	Quarterly Results This is to inform you that the Board of Directors at its meeting held today i.e. 8th November 2024, has inter alia approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September 2024. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2024 along with Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.45 AM and concluded at 1.45 P.M. (As Per BSE Announcement dated on 08.11.2024)
06-Aug-2024	14-Aug-2024	Quarterly Results	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June 2024. The Board at its meeting held on 14.08.2024 has inter alia approved: 1. Re-appointment of Smt. Jyothsana Akkineni as Executive Director 2. Re-appointment of Sri K Purushotham Naidu as Director - Finance and Commercial 3. Re-appointment of Sri Yugandhar Meka as Independent Director 4. Appointment of Sri Ravi Prasad Gorthy as Independent Director (Additional) 5. Appointment of Sriramamurthy & Co as Internal Auditors for FY 24-25 6. Appointment of JK & Co as Cost Auditors for FY 24-25 7. Appointment of Sri G.M.V. Dhanunjaya Rao (GMVDR & Associates) as Secretarial Auditors for FY 24-25. (As Per BSE Announcement dated on 15.08.2024)
10-Jun-2024	10-Jun-2024	Disinvestments	Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors at it meeting held today i.e. 10.06.2024, have approved disinvestment/winding up of Jordanian Renewable Aluminium Fluoride Manufacturing Company P.S.C. (Jordan Company), a step down subsidiary company in The Hashemite Kingdom of Jordan. This has been decided considering the geo-political instability in the Middle East and the fact that the step down subsidiary has not commenced its business operations till date. The Board suggested to explore opportunities in domestic/international markets. At present, the decision for disinvestment/winding up is at a primary stage and the same shall be discussed further with the JV Partners by Alufluoride International Pte. Ltd., Singapore, subsidiary company. The Company shall provide necessary updates on this as and when communication is received from Alufluoride International Pte. Ltd, Singapore, subsidiary company and the Jordan Company.
16-May-2024	23-May-2024	Final Dividend	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve 1. The Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March 2024; and 2. Recommend final dividend for the financial year 2023-2024 as may be approved by the Board of Directors of the Company if any. Kindly take note of the same. This is to inform that the Board of Directors at its meeting held today i.e. 23rd May, 2024, has, inter alia: 1. Approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2024; 2. Recommended a final dividend of INR 3/- (Rupees Three only) per equity share of INR 10/- each (i.e. 30% on the face value of INR 10 each) for the financial year ended 31st March, 2024, for the approval of the shareholders of the Company at the ensuing Annual General Meeting. Accordingly, we are enclosing herewith Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2024 along with Auditor's Report thereon. The meeting of the Board of Directors of the Company commenced at 11.45 AM and concluded at 2.55 P.M. Kindly take the same on record. (As Per BSE Announcement Dated on: 23/05/2024)
31-Jan-2024	09-Feb-2024	Quarterly Results	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2023. The Board of Directors at its meeting held today i.e. 9th February, 2024, has, inter alia approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2023. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2023. These results have been subjected to limited review by statutory auditors who have expressed an unmodified review report. The Limited Review Report of the Statutory Auditors of the Company is enclosed herewith. The meeting of the Board of Directors of the Company commenced at 12.30 P.M. and concluded at 2.45 P.M. Kindly take the same on record. (As Per BSE Announcement dated on 09.02.2024)
25-Oct-2023	03-Nov-2023	Quarterly Results	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September 2023. Kindly take note of the same. The Board of Directors at its meeting held today i.e. 3rd November, 2023, has, inter alia: 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2023. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Statutory Auditors for the quarter and half year ended 30th September, 2023. 2. Fixed the date of the Extra-ordinary General Meeting of the Company as 11th December, 2023 for appointment of Sri Sohrab Chinoy Kersasp (DIN: 03300321) as Non-Executive and Independent Director of the Company. The meeting of the Board of Directors of the Company commenced at 12.00 P.M. and concluded at 1.45 P.M. The Board of Directors at its meeting held today i.e. 3rd November, 2023 has inter alia approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30.09.2023. Accordingly, we are enclosing herewith the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter and half year ended 30.09.2023. Kindly take the same on record. (As Per BSE Announcement Dated on 03.11.2023)
17-Sep-2023	16-Sep-2023	Change in Directors	The Board of Directors at its meeting held on Saturday, 16th September, 2023, has, inter alia approved: 1. Appointment of Sri Sohrab Chinoy Kersasp (DIN: 03300321) as an Additional Director (Non-Executive & Independent) on the Board of the Company w.e.f. 16th September 2023 2. Re-designation of Sri Yugandhar Meka as Chairman and Non-Executive Independent Director of the Company 3. Reconstitution of Audit Committee and Nomination and Remuneration Committee 4. Appointment of M/s Sriramamurthy & Co, Chartered Accountants as the Internal Auditor of the Company for FY 2023-2024 5. Appointment of M/s JK & Co, Cost Accountants as the Cost Auditor of the Company for FY 2023-2024. 6. Appointment of Sri G.M.V. Dhanunjaya Rao (GMVDR & Associates) as the Secretarial Auditor of the Company for FY 2023-2024 Kindly take the same on record. (As Per BSE Announcement Dated on 17.09.2023)
20-Jul-2023	29-Jul-2023	Quarterly Results	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June 2023. Kindly take note of the same. The Board of Directors at its meeting held today i.e. 29th July, 2023, has, inter alia approved Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2023. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Statutory Auditors of the Company for the quarter ended 30th June, 2023. The Board of Directors at it meeting held today i.e. 29 July, 2023 has inter alia approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2023. Accordingly, we are enclosing the Unaudited Standalone and Consolidated Financial Results along with the Limited Review Report for the quarter ended 30 June 2023. (As Per BSE Announcement Dated on 29.07.2023)
16-May-2023	24-May-2023	Accounts	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 inter alia to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March 2023. Kindly take note of the same. The Board Meeting to be held on 23/05/2023 has been revised to 24/05/2023 With reference to our earlier intimation dated 16th May, 2023 and partial modification thereof, intimation is hereby given in terms of Regulation 29 read with Regulation 33 of SEBI (Listing Obligation and & Disclosure Requirements) Regulations, 2015, this is to inform you that due to inevitable circumstance, the meeting of the Board of Directors of the Company which was scheduled to be held on Tuesday, 23rd May, 2023 is postpone and re-scheduled to be held on Wednesday, 24th May, 2023 inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2023 and to recommend final dividend, as may be approved by the Board. (As Per BSE Announcement Dated on 20.05.2023) This is to inform that the Board at its meeting held today i.e. 24 May 2023, has inter alia: 1. Fixed the date of the ensuing Annual General Meeting of the Company as 15 July 2023; 2. Recommended a final dividend of INR 2/- per equity share of INR 10/- each for the financial year ended 31 March 2023 and fixed the record date for the purpose of payment of final dividend as 30 June 2023. Kindly take the same on record. This is to inform that the Board at its meeting held today i.e. 24 May 2023, has inter alia: 1. Approved Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2023; 2. Based on recommendation of NRC and Audit Committee, approved reappointment of Sri Venkat Akkineni (DIN: 00013996) as Managing Director of the Company; 3. Fixed the date of the ensuing Annual General Meeting of the Company as 15 July 2023; 4. Recommended a final dividend of INR 2/- per equity share of INR 10/- each for the financial year ended 31 March 2023 and fixed the record date for the purpose of payment of final dividend as 30 June 2023. The meeting commenced at 12.00 PM and concluded at 2.10 P.M. (As Per BSE Announcement Dated on 24.05.2023) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors at its meeting held on 24th May, 2023, has, inter alia based on recommendation of Nomination and Remuneration Committee and Audit Committee approved the reappointment of Sri Venkat Akkineni (DIN: 00013996) as Managing Director of the Company for a period of five years with effect from 1st August, 2023 to 31st July, 2028, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 25.05.2023)
19-Jan-2023	30-Jan-2023	Quarterly Results	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2022. In reference to our earlier intimation dated 19th January, 2023 and pursuant to Regulation 30 read with Regulation 33 of SEBI LODR Regulations, 2015, this is to inform you that the Board of Directors at its meeting held today i.e. 30th January, 2023, has, inter alia approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2022. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2022 along with the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.30 A.M. and concluded at 1.20 P.M. In reference to our earlier intimation dated 19th January, 2023 and pursuant to Regulation 30 read with Regulation 33 of SEBI LODR Regulations, 2015, this is to inform you that the Board of Directors at its meeting held today i.e. 30th January, 2023, has, inter alia approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2022. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2022 along with the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.30 A.M. and concluded at 1.20 P.M. (As per BSE Announcement Dated on 30/01/2023)
21-Oct-2022	28-Oct-2022	Quarterly Results	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September 2022. In reference to our earlier intimation dated 21 October, 2022 and pursuant to Regulation 30 read with Regulation 33 of SEBI LODR Regulations, 2015, this is to inform you that the Board of Directors at its meeting held today i.e. 28 October 2022, has, inter alia approved Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2022. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September, 2022 along with the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 10.30 A.M. and concluded at 12.20 P.M. Kindly take the same on record. In reference to our earlier intimation dated 21 October, 2022 and pursuant to Regulation 30 read with Regulation 33 of SEBI LODR Regulations, 2015, this is to inform you that the Board of Directors at its meeting held today i.e. 28 October 2022, has, inter alia approved Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2022. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September, 2022 along with the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 10.30 A.M. and concluded at 12.20 P.M. Kindly take the same on record. (As Per BSE Announcement Dated on 28.10.2022)
26-Jul-2022	02-Aug-2022	Quarterly Results	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2022 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June 2022. Kindly take note of the same. In reference to our earlier intimation dated 26th July, 2022 and pursuant to Regulation 30 read with Regulation 33 of SEBI LODR Regulations, 2015, this is to inform you that the Board of Directors at its meeting held today i.e. 2nd August, 2022, has, inter alia: 1. Approved Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2022. 2. Based on recommendation of Audit Committee, approved appointment of M/s Sriramamurthy & Co, Chartered Accountants, as the Internal Auditor of the Company. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2022 along with the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.30 A.M. and concluded at 1.30 P.M. Kindly take the same on record. Regulations, 2015, this is to inform you that the Board of Directors at its meeting held today i.e. 2nd August, 2022, has, inter alia: 1. Approved Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2022. 2. Based on recommendation of Audit Committee, approved appointment of M/s Sriramamurthy & Co, Chartered Accountants, as the Internal Auditor of the Company. Accordingly, we are enclosing herewith Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2022 along with the Limited Review Report of the Statutory Auditors of the Company. The meeting of the Board of Directors of the Company commenced at 11.30 A.M. and concluded at 1.30 P.M. Kindly take the same on record. (As Per BSE Announcement Dated on 02.08.2022)
20-May-2022	28-May-2022	Accounts	ALUFLUORIDE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday 28th May 2022 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March 2022. Kindly take note of the same. This is to inform that the Board at its meeting held today i.e. 28.05.2022, has inter alia: 1. Approved Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2022; 2. Based on recommendation of NRC and Audit Committee, approved reappointment of Smt. Jyothsana Akkineni as Executive Director; 3. Based on recommendation of NRC and Audit Committee, approved reappointment of Sri K. Purushotham Naidu as Director - Finance & Commercial; 4. Based on recommendation of Audit Committee, approved reappointment of Brahmayya & Co, Chartered Accountants, Visakhapatnam as Statutory Auditors for second term of five years commencing from FY22-23; 5. Fixed the date of ensuing Annual General Meeting of the Company; 6. Recommended a final dividend of INR 1/- per equity share of INR 10/- each for the financial year ended 31.03.2022 and fixed the record date for the purpose of payment of final dividend. The meeting commenced at 12.15 PM and concluded at 5.15 P.M. This is to inform you that the Board of Directors at its meeting held today i.e. 28th May, 2022, has, inter alia approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2022. Accordingly, we are enclosing herewith Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2022 along with Auditor's Report thereon. The Company hereby declares that the Auditors have expressed an unmodified opinion in the Audit Reports on Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2022. The meeting of the Board of Directors of the Company commenced at 12.15 PM and concluded at 5.15 P.M. Kindly take the same on record. (As per BSE Announcement Dated on 28.05.2022) This is to inform you that the Board of Directors at its meeting held on 28th May, 2022, has, inter alia based on recommendation of Nomination and Remuneration Committee and Audit Committee approved: 1. Reappointment of Smt. Jyothsana Akkineni (DIN: 00150047) as Executive Director for the Company for a further period effective from 6th May 2022 to 30th September 2024, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting; 2. Reappointment of Sri K. Purushotham Naidu (DIN: 01883663) as Director (Finance & Commercial) of the Company for a further period effective from 6th May 2022 to 30th September, 2024, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting. The details of Smt. Jyothsana Akkineni and Sri K. Purushotham Naidu pursuant to Regulations 30 of SEBI (LODR) Regulation, 2015 are enclosed as Annexure A. Kindly take the same on record. (As Per BSE Announcement Dated on 29.05.2022) Alufluoride Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2022, inter alia, has recommended a final dividend of INR 1/- (Rupees One only) per equity share of INR 10/- each (i.e. 10% on the face value of INR 10 each) for the financial year ended March 31, 2022, for the approval of the shareholders of the Company at the ensuing Annual General Meeting and fixed the record date for the purpose of payment of final dividend. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors at its meeting held on 28th May, 2022 has inter alia, based on recommendation of Audit Committee, approved the reappointment of Brahmayya & Co., Chartered Accountants, Visakhapatnam (Firm Registration No. 000513S) as Statutory Auditors of the Company for second term of five years commencing from F.Y. 2022-23, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The details of Brahmayya & Co., Chartered Accountants pursuant to Regulations 30 of SEBI (LODR) Regulation, 2015 are enclosed as Annexure A. Kindly take the same on record. (As Per BSE Announcement Dated on 30.05.2022)

1 2

LOGIN HERE

Alufluoride Ltd

Board Meeting